South and Central America Transcatheter Heart Valves Market (2022-2033)

Higher incidence of structural valve diseases

In South and Central America, valvular heart diseases continue to be a major cardiovascular health challenge. Rheumatic heart disease remains prevalent in many parts of the region, particularly affecting younger populations in rural and underserved areas. Urban centers are seeing an increase in age-related degenerative valve conditions, such as aortic stenosis and mitral regurgitation, due to rising life expectancy and lifestyle factors such as obesity and hypertension. As cardiac imaging and diagnostic access improve in cities, more patients are diagnosed at stages where intervention is necessary, highlighting the need for advanced treatment options.

Access to conventional open-heart surgery can be limited in many parts of South and Central America. Rural patients often face long travel distances to reach specialized cardiac centers, and surgical procedures can be costly or delayed due to hospital capacity constraints. Transcatheter heart valve therapies provide a minimally invasive alternative that reduces risk, recovery time, and hospital resource usage. This is particularly beneficial for older patients or those with comorbidities, helping hospitals expand care for patients who were previously considered high-risk or ineligible for surgery.

Governments and public-private initiatives are increasingly investing in cardiac care infrastructure, including catheterization labs and training for interventional cardiologists. Awareness campaigns and improved referral networks are also helping to identify patients earlier. These factors make the rising prevalence of valvular heart disease a key driver for the adoption of transcatheter heart valves across South and Central America.

Advancements in mitral and tricuspid THV applications

Transcatheter interventions in South and Central America traditionally focused on aortic valves. However, there is an increasing attention on mitral and tricuspid valve disorders. Advanced imaging techniques and growing clinical expertise in urban cardiac centers are allowing physicians to diagnose these complex valve conditions more accurately. Hospitals in cities such as São Paulo, Buenos Aires, Mexico City, and Bogotá are expanding their procedural offerings, creating new opportunities for device manufacturers and healthcare providers.

Patients with mitral or tricuspid valve dysfunction are often older or have other health issues that make conventional surgery risky. Minimally invasive transcatheter therapies offer a safer alternative with faster recovery and reduced complication rates. Referral systems from smaller hospitals to urban cardiac centers are also increasing patient access to these procedures, boosting adoption and awareness throughout the region.

For medical device companies, this segment presents a significant growth opportunity. By providing training, procedural support, and educational programs, they can help local cardiologists build expertise in these interventions. As physician confidence and patient awareness increase, mitral and tricuspid valve therapies are poised to become a key growth segment in the South and Central American transcatheter heart valve market.

The "South and Central America Transcatheter Heart Valves Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• South and Central America Transcatheter Heart Valves market size and forecast at regional and country levels for key market segments covered under the scope
• South and Central America Transcatheter Heart Valves market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• South and Central America Transcatheter Heart Valves market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Transcatheter Heart Valves market
• Detailed company profiles, including SWOT analysis

The geographical scope of the South and Central America Transcatheter Heart Valves market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2024.

Brazil dominates the South and Central America transcatheter heart valves market due to its scale, infrastructure, and strategic healthcare investments. Major urban centers such as São Paulo, Rio de Janeiro, and Brasília have become focal points for advanced cardiac interventions, with leading hospitals increasingly performing transcatheter aortic valve replacement (TAVR) and related procedures. The country's leadership is reinforced by government-backed initiatives to expand tertiary care facilities, improve insurance coverage, and strengthen access to specialized cardiac services. Brazil's growing role in medical research and training enhances its position, as local physicians participate in international clinical trials and specialized programs.

Collaborations with global MedTech companies have accelerated the introduction of new valve technologies, while medical tourism adds another dimension to its dominance, attracting patients from neighboring countries seeking advanced treatments. Nonetheless, challenges persist. Rural populations often face limited access to specialized cardiac care, and the high cost of imported devices continues to be a barrier for broader adoption. Despite these limitations, Brazil remains the benchmark for transcatheter heart valve adoption in South and Central America, setting the standard for innovation, accessibility, and regional growth in minimally invasive cardiac interventions.

• The report includes qualitative and quantitative data in the South and Central America Transcatheter Heart Valves market across valve type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Transcatheter Heart Valves market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Transcatheter Heart Valves market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Transcatheter Heart Valves market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover South and Central America Transcatheter Heart Valves market segments by valve type, application, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the South and Central America Transcatheter Heart Valves market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The South and Central America Transcatheter Heart Valves market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes crucial corporate publications, association data, and databases. A few of the key developments in the South and Central America Transcatheter Heart Valves market are:

• In October 2024, Terumo Blood and Cell Technologies announced it was scaling up its operations across Latin America, specifically targeting Brazil, Colombia, and Mexico. This expansion aims to promote automated manufacturing and increase the availability of specialized interventional tools. By localizing more of its support and supply chain, Terumo is working to ensure that its high-demand guidewires and access sheaths are more readily available to regional firms and hospitals transitioning to advanced cell and gene therapies, as well as traditional cardiovascular procedures.
• In February 2024, Medtronic announced the regional rollout of its Stedi Extra Support Guidewire in key Latin American markets, including Brazil and Mexico. This guidewire is optimized for use in complex Transcatheter Aortic Valve Replacement (TAVR) procedures. The "extra support" design provides the stability and shape retention necessary for clinicians in the region to navigate difficult anatomy, supporting the rising volume of structural heart interventions across South America's major cardiac centers.